My research focuses on outcomes in treatment of muscle invasive and high-grade non-muscle invasive bladder cancer. This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management. We are particularly interested in the impact of surgical quality measures on outcome for patients with invasive disease.